Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKesson
Federal Trade Commission
Argus Health
Baxter
Dow
Cipla
QuintilesIMS
Citi

Generated: November 21, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Ulimorelin

« Back to Dashboard

US Patents for Ulimorelin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ulimorelin ➤ Try a Free Trial Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists Tranzyme Pharma, Inc. (CA) ➤ Try a Free Trial
Ulimorelin ➤ Try a Free Trial Macrocyclic modulators of the ghrelin receptor Tranzyme Pharma, Inc. (Quebec, CA) ➤ Try a Free Trial
Ulimorelin ➤ Try a Free Trial Methods of using macrocyclic modulators of the ghrelin receptor Tranzyme Pharma Inc. (Quebec, CA) ➤ Try a Free Trial
Ulimorelin ➤ Try a Free Trial Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders Tranzyme Pharma Inc. (CA) ➤ Try a Free Trial
Ulimorelin ➤ Try a Free Trial Pharmaceutical salts of macrocyclic modulators of the ghrelin receptor Tranzyme Pharma Inc. (CA) ➤ Try a Free Trial
Ulimorelin ➤ Try a Free Trial Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor Tranzyme Pharma Inc. (CA) ➤ Try a Free Trial
Ulimorelin ➤ Try a Free Trial Methods of using macrocyclic modulators of the ghrelin receptor Tranzyme Pharma Inc. (CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Ulimorelin

Drugname Country Document Number Estimated Expiration Related US Patent
Ulimorelin Austria 490264 2023-07-31 ➤ Try a Free Trial
Ulimorelin Australia 2004261329 2023-07-31 ➤ Try a Free Trial
Ulimorelin Canada 2533818 2023-07-31 ➤ Try a Free Trial
Ulimorelin Cyprus 1111901 2023-07-31 ➤ Try a Free Trial
Ulimorelin Germany 602004030344 2023-07-31 ➤ Try a Free Trial
Ulimorelin Denmark 1648922 2023-07-31 ➤ Try a Free Trial
Ulimorelin European Patent Office 1648922 2023-07-31 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Deloitte
Teva
Cantor Fitzgerald
Moodys
Medtronic
Daiichi Sankyo
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.